Jin Medical International Ltd (NASDAQ: ZJYL) has a price-to-earnings ratio that is above its average at 20.91x. The stock has a 36-month beta value of 9.53.
The public float for ZJYL is 37.82M, and at present, short sellers hold a 0.46% of that float. On February 12, 2026, the average trading volume of ZJYL was 608.20K shares.
ZJYL stock’s latest price update
Jin Medical International Ltd (NASDAQ: ZJYL)’s stock price has plunge by 13.50%relation to previous closing price of $0.14. Nevertheless, the company has seen a 13.50% surge in its stock price over the last five trading sessions.
ZJYL’s Market Performance
Jin Medical International Ltd (ZJYL) has seen a 13.50% rise in stock performance for the week, with a -35.72% decline in the past month and a -39.30% plunge in the past quarter. The volatility ratio for the week is 10.47%, and the volatility levels for the past 30 days are at 19.98% for ZJYL. The simple moving average for the past 20 days is 11.60% for ZJYL’s stock, with a -67.51% simple moving average for the past 200 days.
ZJYL Trading at -17.66% from the 50-Day Moving Average
After a stumble in the market that brought ZJYL to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -84.50% of loss for the given period.
Volatility was left at 19.98%, however, over the last 30 days, the volatility rate increased by 10.47%.
Stock Fundamentals for ZJYL
Current profitability levels for the company are sitting at:
- 0.09% for the present operating margin
- 0.37% for the gross margin
The net margin for Jin Medical International Ltd stands at 0.08%. The total capital return value is set at 0.07%. Equity return is now at value 4.08%, with 2.40% for asset returns.
Based on Jin Medical International Ltd (ZJYL), the company’s capital structure generated 0.36 points at debt to capital in total, while cash flow to debt ratio is standing at 0.08. The debt to equity ratio resting at 0.57. The interest coverage ratio of the stock is 9.09.
Currently, EBITDA for the company is $3.98 million with net debt to EBITDA at 2.17. When we switch over and look at the enterprise to sales, we see a ratio of 1.3. The receivables turnover for the company is 4.06for trailing twelve months and the total asset turnover is 0.47. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.85.
Conclusion
To sum up, Jin Medical International Ltd (ZJYL) has seen a bad performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.